Literature DB >> 33706657

Base rates of invalidity when patients undergoing routine clinical evaluations have social security disability as an external incentive.

Ryan W Schroeder1, Hilary A Clark1, Phillip K Martin1.   

Abstract

Objective: Social Security Disability is a common external incentive in neuropsychological evaluations. This study determined base rates of invalidity when patients referred for routine clinical evaluations have Social Security Disability as an external incentive. Method: Patients (n = 242) were grouped as validly or invalidly performing based on the use of multiple performance validity tests. Frequency analyses were then conducted.
Results: As a whole, 46.0% of clinically referred patients with Social Security Disability as an external incentive produced invalid data. When divided by disability pursuit status, 58.6% of individuals already receiving Social Security Disability, 44.6% of individuals actively seeking Social Security Disability, and 39.3% of individuals considering seeking Social Security Disability produced invalid data. By comparison, only 8.5% of clinically referred patients without known external incentives produced invalid data. Conclusions: Beyond establishing base rates, these data indicate that the external incentive, not necessarily the evaluation setting, increases the rate of invalidity, as obtained base rates mirror those observed in independent medical examinations. In addition, this study highlights that even patients who report that they are considering but have not committed themselves to pursuing an external incentive frequently invalidate testing.

Entities:  

Keywords:  Social security disability; base rate; clinical evaluations; external incentive; invalidity

Year:  2021        PMID: 33706657     DOI: 10.1080/13854046.2021.1895322

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   4.373


  1 in total

1.  Prevalence Estimates of Symptom Feigning and Malingering in Spain.

Authors:  Esteban Puente-López; David Pina; Reyes López-López; Héctor González Ordi; Irena Bošković; Thomas Merten
Journal:  Psychol Inj Law       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.